Home Cajal Neuroscience

Cajal Neuroscience

In operation
Series A
Developer of Neurodegenerative Disease Treatments
Basic
Enterprise Profile

Basic Information

Cajal Neuroscience is a biotechnology company dedicated to discovering new therapies for neurodegenerative diseases by leveraging a powerful platform designed to reveal the mechanisms, spatial, and temporal complexity of diseases on an unprecedented scale. Cajal integrates a set of state-of-the-art methods and technologies, including human genetics and multi-omics integration, high-throughput functional genomics, and advanced microscopy, to accelerate neurodegeneration target and drug discovery.
Cajal Neuroscience, Inc.
Seattle,Washington,United States of America
15~50 people
January 01, 2020
info@cajalneuro.com

Enterprise Profile

Industrial Sector
New Drug Development CRO
Technology
Biotechnology
Concept
# Nervous System Diseases
Application Scenarios
Innovative Drugs